A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease - Join Clinical Trial NCTNCT06283966
How to Join This Clinical Trial - NCTNCT06283966
Learn how to participate in this PHASE3 trial studying an investigational therapy for Lung Diseases, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Lung Diseases, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Lung Diseases, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE3 - Large-scale efficacy study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06283966 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 892 locations. Find a study site near you:
Clinical Research Site
Athens, Alabama 35611 - United States
Status: TERMINATED
Clinical Research Site
Cullman, Alabama 35058 - United States
Status: RECRUITING
Clinical Research Site
Fairhope, Alabama 36532 - United States
Status: TERMINATED
Clinical Research Site
Huntsville, Alabama 35801 - United States
Status: TERMINATED
Clinical Research Site
Mobile, Alabama 36608 - United States
Status: RECRUITING
Clinical Research Site
Sheffield, Alabama 35660 - United States
Status: WITHDRAWN
Clinical Research Site
Gilbert, Arizona 85296 - United States
Status: RECRUITING
Clinical Research Site
Glendale, Arizona 85308 - United States
Status: WITHDRAWN
Clinical Research Site
Mesa, Arizona 85206 - United States
Status: RECRUITING
Clinical Research Site
Mesa, Arizona 85213 - United States
Status: RECRUITING
And 882 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE3 clinical trial for Lung Diseases, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships